MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 46 filers reported holding MEDAVAIL HOLDINGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $586 | -14.5% | 2,389,478 | 0.0% | 0.11% | -19.9% |
Q1 2023 | $685 | -4.3% | 2,389,478 | 0.0% | 0.14% | -8.7% |
Q4 2022 | $716 | -100.0% | 2,389,478 | 0.0% | 0.15% | -63.7% |
Q3 2022 | $1,854,000 | -49.3% | 2,389,478 | 0.0% | 0.41% | -43.6% |
Q2 2022 | $3,656,000 | +57.6% | 2,389,478 | 0.0% | 0.73% | +155.1% |
Q1 2022 | $2,320,000 | -30.6% | 2,389,478 | 0.0% | 0.28% | +8.8% |
Q4 2021 | $3,345,000 | -52.1% | 2,389,478 | 0.0% | 0.26% | -49.6% |
Q3 2021 | $6,977,000 | -76.2% | 2,389,478 | 0.0% | 0.52% | -75.1% |
Q2 2021 | $29,271,000 | +306.3% | 2,389,478 | +364.3% | 2.09% | +322.0% |
Q1 2021 | $7,205,000 | – | 514,668 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 300,588 | $1,803,528 | 8.66% |